ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nanoparticle-Based MRI-Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF-β Signaling

Zhou, Rui; Liu, Yantan; Wang, Zhaojun; Lv, Jinyu; Liao, Wangjun*; Shen, Zheyu*; Rong, Xiaoxiang*南方医科大学
Advanced Healthcare Materials2023-8DOI: 10.1002/adhm.202300176
3被引8阅读
引用收藏
分享

摘要

Although induction of ferroptosis and inhibition of transforming growth factor-beta (TGF-beta) signaling are both effective ways to reform the tumor microenvironment (TME) and render low-immunogenic tumors responsive to immune checkpoint inhibitor therapy, dose-limiting side effects remain major obstacles hindering their clinical application. Herein, novel sorafenib and anti-TGF-beta antibody loaded Fe3O4/Gd2O3 hybrid nanoparticles with conjugation of arginine-glycine-aspartic dimer (FeGd-HN@Sorafenib@TGF-beta-antibody@RGD2, FG-STR) are developed. Sorafenib significantly enhances FeGd-HN-triggered ferroptosis and improves maturation and phagocytosis of dendritic cells (DCs) by inducing damage-associated molecular patterns released from ferroptotic cancer cells, while the anti-TGF-beta antibody further synergizes with enhanced ferroptosis to promote DC maturation and the recruitment of CD8(+) T cells, thus heating the TME. Moreover, the incorporation of RGD2 facilitates the uptake of the FG-STR in tumor cells which lead to a significant dosage reduction of both sorafenib and anti-TGF-beta antibody to avoid dose-limiting toxicities. Finally, in vitro and in vivo experiments show that FG-STR has significantly superior intrinsic magnetic resonance imaging (MRI) capability than that of Gadovist, effectively inhibits tumor growth and lung metastasis, and increases the efficacy of anti-programmed cell death-1 treatment. Taken together, this study provides a promising strategy for new advanced MRI-guided TME heating therapies.

学科与关键词

关键词
ferroptosisimmunotherapymagnetic nanoparticlesmagnetic resonance imagingtransforming growth factor-betatumor microenvironments
相关
加载中…
  • A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy
    Guo, Shuai; Xiong, Wei; Zhu, Jiaoyang; Feng, Jie; Zhou, Ruilong; Fan, Qingdeng; Zhang, Qianqian; Li, Zongheng; Yang, Jing; Zhou, Huimin; Yi, Peiwei; Feng, Yanqiu; Yang, Sugeun; Qiu, Xiaozhong; Xu, Yikai; Shen, Zheyu*Biomaterials, 2023, 302: 122300.被引 5
  • Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis Therapy
    Zhou, Huimin; Lu, Xuanyi; Du, Chao; Zhou, Zijian*; Feng, Jie; Liang, Zhiyu; Xu, Yikai*; Qiu, Xiaozhong*; Shen, Zheyu*Small, 2022, 18(35): 2202705.被引 16
  • A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling
    Huang, Lin; Feng, Jie*; Zhu, Jiaoyang; Yang, Jing; Xiong, Wei; Lu, Xuanyi; Chen, Sijin; Yang, Sugeun; Li, Yan; Xu, Yikai*; Shen, Zheyu*Advanced Healthcare Materials, 2023, 12(18): 2203362.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
Advanced Healthcare Materials
发表日期
2023-08
卷期
第 12 卷, 第 21 期
DOI
10.1002/adhm.202300176
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82073375, 82102731, 82073303]; Natural Science Foundation of Guangdong Province of China [2020A1515110686, 2022A1515012418]; Science and Technology Planning Project of Guangzhou [202102020532]

作者

  • Z

    Zhou, Rui (第一作者)

    southern med univ

  • L

    Liu, Yantan

    southern med univ

查看全部 7 位作者收起作者
  • W

    Wang, Zhaojun

    southern med univ

  • L

    Lv, Jinyu

    southern med univ

  • L

    Liao, Wangjun (通讯)

    southern med univ

  • S

    Shen, Zheyu (通讯)

    southern med univ

  • R

    Rong, Xiaoxiang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417